Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report
Abstract Background Bruxism refers to grind or gnash the opposing rows of upper and lower molar teeth. It is important to treat bruxism as a factor that can influence sleep quality, quality of life, and mental status in patients with malignancy. Case presentation A 41-year-old male developed bruxism...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2020-03-01
|
| Series: | JA Clinical Reports |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s40981-020-00329-4 |
| id |
doaj-ddf71d108edd4b359c57fc74edc3ccf7 |
|---|---|
| record_format |
Article |
| spelling |
doaj-ddf71d108edd4b359c57fc74edc3ccf72021-04-02T12:29:16ZengSpringerOpenJA Clinical Reports2363-90242020-03-01611210.1186/s40981-020-00329-4Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case reportMohsen Khosravi0Department of Psychiatry and Clinical Psychology, Baharan Psychiatric Hospital, Zahedan University of Medical SciencesAbstract Background Bruxism refers to grind or gnash the opposing rows of upper and lower molar teeth. It is important to treat bruxism as a factor that can influence sleep quality, quality of life, and mental status in patients with malignancy. Case presentation A 41-year-old male developed bruxism secondary to cerebral glioblastoma. l-dopa, gabapentin, clonazepam, clonidine, baclofen, buspirone, or propranolol were not effective. Mirtazapine, prescribed for side effects of chemotherapy, was effective for bruxism, which was disappeared within 3 weeks. Conclusions Mirtazapine was effective for treating bruxism as well as chemotherapy complications.http://link.springer.com/article/10.1186/s40981-020-00329-4BruxismGlioblastomaMirtazapine |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Mohsen Khosravi |
| spellingShingle |
Mohsen Khosravi Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report JA Clinical Reports Bruxism Glioblastoma Mirtazapine |
| author_facet |
Mohsen Khosravi |
| author_sort |
Mohsen Khosravi |
| title |
Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report |
| title_short |
Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report |
| title_full |
Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report |
| title_fullStr |
Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report |
| title_full_unstemmed |
Treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report |
| title_sort |
treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report |
| publisher |
SpringerOpen |
| series |
JA Clinical Reports |
| issn |
2363-9024 |
| publishDate |
2020-03-01 |
| description |
Abstract Background Bruxism refers to grind or gnash the opposing rows of upper and lower molar teeth. It is important to treat bruxism as a factor that can influence sleep quality, quality of life, and mental status in patients with malignancy. Case presentation A 41-year-old male developed bruxism secondary to cerebral glioblastoma. l-dopa, gabapentin, clonazepam, clonidine, baclofen, buspirone, or propranolol were not effective. Mirtazapine, prescribed for side effects of chemotherapy, was effective for bruxism, which was disappeared within 3 weeks. Conclusions Mirtazapine was effective for treating bruxism as well as chemotherapy complications. |
| topic |
Bruxism Glioblastoma Mirtazapine |
| url |
http://link.springer.com/article/10.1186/s40981-020-00329-4 |
| work_keys_str_mv |
AT mohsenkhosravi treatmentofcerebralglioblastomacausedbruxismwithmirtazapineacasereport |
| _version_ |
1721568791925620736 |